Device / Technology News

RSS

Siteman Cancer Center to test radiotherapy system from ViewRay

Researchers at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Missouri, a national leader in the early adoption and use of advanced treatments for cancer patients, will soon become the first in the world to test an innovative radiotherapy system from ViewRay, Inc. The ViewRay system is designed to improve the accuracy of cancer treatments through a combination of medical imaging and radiotherapy delivery.

4 Aug 2010

Merck-Chimie to commercialize CardioGenics' proprietary paramagnetic beads

CardioGenics Holdings Inc., developer of the ultra-sensitive QL Care™ Point-Of-Care (POC) analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced that CardioGenics Inc. and Merck Chimie S.A.S. have agreed on a plan to commercialize CardioGenics' proprietary paramagnetic beads, with shipments to Merck-Chimie's customers scheduled to start mid-September 2010.

4 Aug 2010

Proton therapy to treat patient’s tumor without compromising quality of life

The radiation oncologist's mantra is to deliver the maximum dose of radiation to the malignant tumor, while limiting damage to healthy surrounding tissue. In proton therapy, this balance is achieved by using proton particles, accelerated to nearly the speed of light, to mimic the shape of a tumor and effectively deposit their energy within the confines of it with sub-millimeter precision.

4 Aug 2010

Victory Pharma acquires assets of MiddleBrook Pharmaceuticals

Victory Pharma, Inc. today announced that it has completed the acquisition of substantially all of the assets of MiddleBrook Pharmaceuticals, Inc..

4 Aug 2010

Biomedical engineering professor receives patent for Electromagnetic Probe Device

The United States Patent Office has issued a patent to Dr. Mark DeCoster, associate professor of biomedical engineering at Louisiana Tech University, for his invention of an "Electromagnetic Probe Device" - an innovative technology developed at Louisiana Tech's Institute for Micromanufacturing.

4 Aug 2010

Researchers discover first combined device for probing, detecting DNA

DNA microarrays are one of the most powerful tools in molecular biology today. The devices, which can be used to probe biological samples and detect particular genes or genetic sequences, are employed in everything from forensic analysis to disease detection to drug development.

4 Aug 2010

GE and Intel create new health IT venture focused on home-based care

General Electric Co. and Intel Corp. announced Monday they will create a company to provide new medical technologies for the elderly and chronically ill.

4 Aug 2010

Spectrum Health selects Aternity FPI Platform for strategic end user experience management initiatives

Aternity Inc., the industry's technology leader in end user experience management solutions for Global 1000 enterprises, announced today that Spectrum Health, a not-for-profit health system in West Michigan that offers a full continuum of care that includes the Spectrum Health Hospital Group, has selected the Aternity Frontline Performance Intelligence (FPI) Platform for its strategic end user experience management initiatives.

4 Aug 2010

New algorithm to reduce radiation dose in CT imaging

In recent years, advances in CT scanner technology have made perfusion computed tomography (CT) imaging an important diagnostic tool for patients with suspected stroke. Now, researchers at Mayo Clinic are working to reduce radiation dosages used to acquire perfusion and other CT images. Mayo Clinic medical physicist Cynthia McCollough, Ph.D., and her group of researchers presented their findings related to CT dose reduction at the 52nd Annual Meeting of the American Association of Physicists in Medicine on July 20 in Philadelphia. The presentation was entitled "20-Fold Dose Reduction Using a Gradient Adaptive Bilateral Filter: Demonstration Using in Vivo Animal Perfusion CT."

4 Aug 2010

BARDA awards contract to develop Pfenex Expression Technology

Pfenex Inc. today announced that the Department of Health and Human Services (HHS), through the Biomedical Advanced Research and Development Authority (BARDA) has awarded Pfenex a contract providing for up to a total of $18.8 million in funding, provided that certain milestones are achieved and that all contract options and extensions are exercised by the government. The contract will support the development of a robust Pfenex Expression Technology based production strain and process for the production of bulk recombinant protective antigen (rPA) from anthrax.

4 Aug 2010

DTB launches Don't Drop Mixtard 30 campaign to change Novo Nordisk's drug removal decision

Drug company Novo Nordisk's decision to pull its Mixtard 30 insulin drug from the UK could add 9 million to the NHS drugs bill in England alone, says an editorial in the Drug and Therapeutics Bulletin (DTB). The decision could also leave thousands of patients dependent on others to help them take their insulin, says DTB, which today launches its "Don't Drop Mixtard 30" campaign to convince the company to change its mind.

4 Aug 2010

QCMG selects SGI LiveArc storage solution for cancer genome sequence data processing

SGI, a global leader in HPC and data center solutions, today announced that the Queensland Centre for Medical Genomics at the University of Queensland has selected SGI LiveArc storage solution to increase its ability to store, manage and process human cancer genome sequence data. This project will contribute to mapping the genetic changes that lead to cancer, providing better understanding of such cancers and potentially helping to combat the disease.

4 Aug 2010

ICU Medical's Neutron Neutral-Pressure Needleless Connector receives FDA clearance

ICU Medical, Inc., a worldwide leader in the development, manufacture and sale of proprietary, disposable medical connection systems for use in vascular therapy applications, today confirmed that it has received FDA 510-k clearance for the Neutron™ Neutral-Pressure Needleless Connector.

4 Aug 2010

Dendreon to implement Pilgrim's Deviation and Corrective and Preventive Action management system

Pilgrim Software, Inc., a world-leading provider of Enterprise Risk, Compliance and Quality Management (ERCQM) software solutions, today announced that Dendreon Corporation, a Seattle-based biotechnology company, will implement Pilgrim's automated system for Deviation and Corrective and Preventive Action (CAPA) management using its on-demand software as a service platform.

4 Aug 2010

Hospitals, docs adopting health IT ahead of schedule

Clinics and hospitals are increasingly switching to electronic medical records as a federal push to spread the technology sweeps across the nation.

4 Aug 2010

Boston Scientific initiates enrollment in EVOLVE clinical trial of SYNERGY Coronary Stent

Boston Scientific Corporation today announced the start of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of its fourth-generation SYNERGY™ Coronary Stent. The first patient was enrolled by Ian Meredith, M.B.B.S., Ph.D., Professor and Director of MonashHeart, at Monash Medical Centre in Melbourne, Australia.

4 Aug 2010

BCM collaborates with Roche NimbleGen for high throughput exome capture technology

The Baylor College of Medicine Human Genome Sequencing Center has standardized its target enrichment human disease research studies on Roche NimbleGen Sequence Capture Exome technology. The Baylor HGSC will sequence over 5,000 exomes in the next two years to identify genetic variants underlying multiple human diseases and will employ NimbleGen SeqCap EZ Exome and customized NimbleGen exome designs as the exome capture technology of choice. More than 15 different diseases will be investigated by Baylor HGSC, including brain, liver, pancreatic, colon, ovarian and bladder cancers, heart disease, diabetes, autism, and other inherited diseases with the goal of better understanding causative mutations and their impact on these diseases.

4 Aug 2010

Simulations Plus releases MedChem Studio software for drug discovery

Simulations Plus, Inc., a leading provider of simulation and modeling software for pharmaceutical discovery and development, has announced the launch of its MedChem Studio™ software for drug discovery.

4 Aug 2010

Cornerstone licenses global rights to alpha-7 technology to Targacept

Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that the Company has licensed to Targacept, Inc. the worldwide rights to its nicotinic-receptor based patents and library of preclinical compounds that target the alpha-7 or other nicotinic receptors originally licensed to Cornerstone from the Feinstein Institute for Medical Research.

4 Aug 2010

CSI launches Diamondback Predator 360 catheter system for treatment of peripheral arterial disease

Cardiovascular Systems, Inc. has launched its second-generation product, the Diamondback Predator 360° PAD System, for the treatment of peripheral arterial disease (PAD). The new device uses the same mechanism of action as the clinically proven Diamondback 360 PAD System with improvements in the crowns and shaft for enhanced clinical performance and shorter procedure times.

4 Aug 2010

Device / Technology News

Siteman Cancer Center to test radiotherapy system from ViewRay

Merck-Chimie to commercialize CardioGenics' proprietary paramagnetic beads

Proton therapy to treat patient’s tumor without compromising quality of life

Victory Pharma acquires assets of MiddleBrook Pharmaceuticals

Biomedical engineering professor receives patent for Electromagnetic Probe Device

Researchers discover first combined device for probing, detecting DNA

GE and Intel create new health IT venture focused on home-based care

Spectrum Health selects Aternity FPI Platform for strategic end user experience management initiatives

New algorithm to reduce radiation dose in CT imaging

BARDA awards contract to develop Pfenex Expression Technology

DTB launches Don't Drop Mixtard 30 campaign to change Novo Nordisk's drug removal decision

QCMG selects SGI LiveArc storage solution for cancer genome sequence data processing

ICU Medical's Neutron Neutral-Pressure Needleless Connector receives FDA clearance

Dendreon to implement Pilgrim's Deviation and Corrective and Preventive Action management system

Hospitals, docs adopting health IT ahead of schedule

Boston Scientific initiates enrollment in EVOLVE clinical trial of SYNERGY Coronary Stent

BCM collaborates with Roche NimbleGen for high throughput exome capture technology

Simulations Plus releases MedChem Studio software for drug discovery

Cornerstone licenses global rights to alpha-7 technology to Targacept

CSI launches Diamondback Predator 360 catheter system for treatment of peripheral arterial disease

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Latest News